Vectorious Medical Technologies
Gil Visokolov has a diverse work experience in various roles and industries. Gil is currently serving as the Senior Director of Product Management at Vectorious Medical Technologies since September 2021. Prior to this, they worked at SolarEdge Technologies as a Product Line Manager from October 2018 to September 2021. Before entering the corporate industry, Gil served in the Israel Defense Forces, where they held multiple roles including Analog Design Engineer, System Engineering, Integration Team Lead, and System Integration Engineer from October 2011 to September 2018. Gil started their career as a Teaching Assistant at Technion - Israel Institute of Technology from March 2009 to September 2011.
Gil Visokolov attended the Technion - Israel Institute of Technology from 2006 to 2009, where they earned a Bachelor of Science degree in Electrical and Electronics Engineering. Gil later pursued a Master of Science degree in the same field at the same institution and graduated in 2011.
Vectorious Medical Technologies
1 followers
Vectorious Medical Technologies developed the V-LAP, the worlds first in-heart microcomputer which enables optimal treatment for heart failure patients, increasing their quality of life and life expectancy.The V-LAP sensory implant is the first digital, wireless, battery-less device that is able to communicate from deep within the body. Itmonitors the heart’s left atrium pressure (LAP) which has been proven to be the earliest, most accurate and effective predictor for heart failure deterioration.Vectorious is actively conducting clinical studies in Europe (Italy, Germany, UK and Israel) for the purpose of obtaining a CE mark. It is expected to launch a clinical study in the US in 2020.